Target trial does not suggest major adverse outcomes with early GLP-1 use in pregnancy
A target trial emulation estimated the risks associated with glucagon-like peptide-1 receptor agonist (GLP-1RA) exposure in early pregnancy. The findings did not indicate a substantially increased risk for nonlive birth, ...
Jun 8, 2026
0
4








